Glutathione S-transferase M1, T1, and P1 polymorphisms and risk of glioma: A meta-analysis

Molecular Biology Reports

Volumn 40, Issue 2, 2013, Pages 1641-1650

  Fan, Zuoxu ^a   Wu, Yaoyao ^b   Shen, Jian ^a   Zhan, Renya ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b People's Liberation Army 117 Hospital   (China)

Author keywords

Glioma; Glutathione S transferase; Meta analysis; Polymorphism

Indexed keywords

GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1;

ARTICLE; CANCER RISK; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; GLIOBLASTOMA; GLIOMA; HUMAN; SINGLE NUCLEOTIDE POLYMORPHISM;

BRAIN NEOPLASMS; CASE-CONTROL STUDIES; GENETIC ASSOCIATION STUDIES; GLIOMA; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; ODDS RATIO; POLYMORPHISM, GENETIC; PUBLICATION BIAS; RISK;

EID: 84878354240     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-2213-8     Document Type: Article

References (41)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225-249
2. Fisher PG, Buffler PA (2005) Malignant gliomas in 2005: where to GO from here? JAMA 293:615-617
3. Ohgaki H, Kleihues P (2005) Epidemiology and etiology of gliomas. Acta Neuropathol 109:93-108
4. Connelly JM, Malkin MG (2007) Environmental risk factors for brain tumors. Curr Neurol Neurosci Rep 7:208-214
5. Bondy ML, Scheurer ME, Malmer B, Barnholtz-Sloan JS, Davis FG, Il'yasova D et al (2008) Brain tumor epidemiology: consensus from the brain tumor epidemiology consortium. Cancer 113:1953-1968
6. Anttila A, Heikkila P, Nykyri E, Kauppinen T, Pukkala E, Hernberg S et al (1996) Risk of nervous system cancer among workers exposed to lead. J Occup Environ Med 38:131-136
7. Zheng T, Cantor KP, Zhang Y, Keim S, Lynch CF (2001) Occupational risk factors for brain cancer: a population-based case-control study in Iowa. J Occup Environ Med 43:317-324
8. Thakur MK, Ghosh S (2010) GST-tagged mouse estrogen receptor alpha-transactivation domain fusion protein is specifically degraded during its over-expression in E. coli and purification. Mol Biol Rep 37:1335-1340
9. Liu D, Liao M, Zuo J, Henner WD, Fan F (2001) The effect of chemical carcinogenesis on rat glutathione S-transferase P1 gene transcriptional regulation. Mol Biol Rep 28:19-25
10. Hayes JD, Pulford DJ (1995) The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 30:445-600
11. Strange RC, Spiteri MA, Ramachandran S, Fryer AA (2001) Glutathione-S-transferase family of enzymes. Mutat Res 482:21-26
12. Saadat I, Saadat M (2010) Influence of genetic polymorphisms of glutathione S-transferase T1 (GSTT1) and M1 (GSTM1) on hematological parameters. Mol Biol Rep 37:249-253
13. Norppa H (2004) Cytogenetic biomarkers and genetic polymorphisms. Toxicol Lett 149:309-334
14. Ali-Osman F, Akande O, Antoun G, Mao JX, Buolamwini J (1997) Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J Biol Chem 272:10004-10012
15. Lai R, Crevier L, Thabane L (2005) Genetic polymorphisms of glutathione S-transferases and the risk of adult brain tumors: a meta-analysis. Cancer Epidemiol Biomarkers Prev 14:1784-1790
16. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 283:2008-2012
17. Lau J, Ioannidis JP, Schmid CH (1997) Quantitative synthesis in systematic reviews. Ann Intern Med 127:820-826
18. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-748
19. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Controlled Clin Trials 7:177-188
20. Grant R, Ironside JW (1995) Glutathione S-transferases and cytochrome P450 detoxifying enzyme distribution in human cerebral glioma. J Neurooncol 25:1-7
21. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088-1101
22. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634
23. Elexpuru-Camiruaga J, Buxton N, Kandula V, Dias PS, Campbell D, McIntosh J et al (1995) Susceptibility to astrocytoma and meningioma: influence of allelism at glutathione S-transferase GSTT1 and GSTM1 and cytochrome P-450 CYP2D6 loci. Cancer Res 55:4237-4239
24. Kelsey KT, Wrensch M, Zuo ZF, Miike R, Wiencke JK (1997) A population-based case-control study of the CYP2D6 and GSTT1 polymorphisms and malignant brain tumors. Pharmacogenetics 7:463-468
25. Wiencke JK, Wrensch MR, Miike R, Zuo Z, Kelsey KT (1997) Population-based study of glutathione S-transferase mu gene deletion in adult glioma cases and controls. Carcinogenesis 18:1431-1433
26. Trizna Z, de Andrade M, Kyritsis AP, Briggs K, Levin VA, Bruner JM et al (1998) Genetic polymorphisms in glutathione S-transferase mu and theta, N-acetyltransferase, and CYP1A1 and risk of gliomas. Cancer Epidemiol Biomarkers Prev 7:553-555
27. Kondrat'eva TV, Imianitov EN, Togo AV, Zatseva OA, Iatsuk OS, Bersnev VP et al (1999) L-myc and GSTM1 polymorphism in cerebral glioma. Vopr Onkol 45:523-527
28. Kondratieva TV, Imyanitov EN, Togo AV, Zaitseva OA, Yatsuk OS, Romanenko SM et al (2000) L-MYC and GSTM1 polymorphisms are associated with unfavourable clinical parameters of gliomas. J Exp Clin Cancer Res 19:197-200
29. Ezer R, Alonso M, Pereira E, Kim M, Allen JC, Miller DC et al (2002) Identification of glutathione S-transferase GST polymorphisms in brain tumors and association with susceptibility to pediatric astrocytomas. J Neurooncol 59:123-134
30. De Roos AJ, Rothman N, Inskip PD, Linet MS, Shapiro WR, Selker RG et al (2003) Genetic polymorphisms in GSTM1, -P1, -T1, and CYP2E1 and the risk of adult brain tumors. Cancer Epidemiol Biomarkers Prev 12:14-22
31. Butler MA, Ruder AM, Daly AK, Waters MA, Carreón T, Schulte PA (2003) Polymorphisms in GSTM1, GSTT1, GSTP1 and NAT2 and susceptibility to primary intracranial brain gliomas. Proc Am Assoc Cancer Res 44:128
32. Wrensch M, Kelsey KT, Liu M, Miike R, Moghadassi M, Aldape K et al (2004) Glutathione-S-transferase variants and adult glioma. Cancer Epidemiol Biomarkers Prev 13:461-467
33. Pinarbasi H, Silig Y, Gurelik M (2005) Genetic polymorphisms of GSTs and their association with primary brain tumor incidence. Cancer Genet Cytogenet 156:144-149
34. Schwartzbaum JA, Ahlbom A, Lönn S, Warholm M, Rannug A, Auvinen A et al (2007) An international case-control study of glutathione transferase and functionally related polymorphisms and risk of primary adult brain tumors. Cancer Epidemiol Biomarkers Prev 16:559-565
35. Custódio AC, Almeida LO, Pinto GR, Santos MJ, Almeida JR, Clara CA et al (2010) GSTP1 Ile105 Val polymorphism in astrocytomas and glioblastomas. Genet Mol Res 9:2328-2334
36. Caram LB, Linefsky JP, Read KM, Murdoch DR, Lalani T, Woods CW et al (2008) Leptotrichia endocarditis: report of two cases from the International Collaboration on Endocarditis (ICE) database and review of previous cases. Eur J Clin Microbiol Infect Dis 27:139-143
37. Okcu MF, Selvan M, Wang LE, Stout L, Erana R, Airewele G et al (2004) Glutathione S-transferase polymorphisms and survival in primary malignant glioma. Clin Cancer Res 10:2618-2625
38. Kilburn L, Okcu MF, Wang T, Cao Y, Renfro-Spelman A, Aldape KD et al (2010) Glutathione S-transferase polymorphisms are associated with survival in anaplastic glioma patients. Cancer 116:2242-2249
39. Grubben MJ, Nagengast FM, Katan MB, Peters WH (2001) The glutathione biotransformation system and colorectal cancer risk in humans. Scand J Gastroenterol Suppl 234:68-76
40. Coles BF, Kadlubar FF (2003) Detoxification of electrophilic compounds by glutathione S-transferase catalysis: determinants of individual response to chemical carcinogens and chemotherapeutic drugs? Biofactors 17:115-130
41. Sadetzki S, Bensal D, Novikov I, Modan B (2003) The limitations of using hospital controls in cancer etiology - one more example for Berkson's bias. Eur J Epidemiol 18:1127-1131